natgillin/translations-raw huggingface dataset:
Very common (may affect more than 1 in 10 people)
Vrlo česte (mogu se javiti u više od 1 na 10 korisnika)
Very common (may affect more than 1 in 10 people)
Vrlo česte (mogu se pojaviti u više od 1 na 10 osoba)
Very common (may affect more than 1 in 10 people)
Vrlo česte nuspojave (mogu se javiti u više od 1 na 10 osoba)
very common (may affect more than 1 in 10 people)
vrlo često (mogu se javiti u do 1 na 10 osoba)
Very common (may affect more than 1 in 10 people)
Vrlo često (mogu se javiti u više od 1 na 10 osoba):
very common (may affect more than 1 in 10 people)
vrlo često (mogu se javiti u više od 1 od 10 osoba)
Very common (may affect more than 1 in 10 people)
Vrlo često (mogu se pojaviti kod više od 1 na 10 osoba)
Very common (may affect more than 1 in 10 people)
Vrlo često (mogu se pojaviti u više od 1 na 10 osoba)
Very common (may affect more than 1 in 10 people)
Vrlo često (može se javiti kod više od 1 na 10 osoba)
Very common (may affect more than 1 in 10 people)
Vrlo često (može se javiti u više od 1 na 10 ljudi)
Very common (may affect more than 1 in 10 people)
Vrlo često (pojavljuju se u 1 na 10 osoba)
Very common (may affect more than 1 in 10 people)
Vrlo često (pojavljuju se u više od 1 na 10 osoba)
Very common (may affect more than 1 in 10 people) blocked nose, sneezing, cough, headache with or without fever - these may be signs of an upper respiratory tract infection.
Vrlo česte (mogu se javiti u više od 1 na 10 osoba) začepljen nos, kihanje, kašalj, glavobolja sa ili bez vrućice – to bi mogli biti znakovi infekcije gornjeg dijela dišnog sustava.
Very common (may affect more than 1 in 10 people) Fever
Vrlo česte (mogu zahvatiti više od 1 od 10 korisnika): vrućica
Very common (may affect more than 1 in 10 people) Fever
Vrlo često (mogu se javiti u više od 1 na 10 osoba) Vrućica
Very common (may affect more than 1 in 10 people) low blood sugar levels (hypo-glycaemia) - when taking this medicine with a sulphonylurea or insulin
Vrlo česte (mogu se javiti u više od 1 na 10 osoba) niska razina šećera u krvi (hipoglikemija) - kod uzimanja ovoga lijeka sa sulfonilurejom ili inzulinom
Very common (may affect more than 1 in 10 people) side effects are:
Vrlo česte (mogu se javiti kod više od 1 na 10 osoba) nuspojave su:
Very common (may affect more than 1 in 10 people) side effects are:
Vrlo česte (mogu se javiti kod više od 1 na10 osoba) nuspojave su:
Very common (may affect more than 1 in 10 people) side effects:
Vrlo česte nuspojave (mogu se javiti u više od 1 na 10 osoba):
Very common (may affect more than 1 in 10 people) vaginal yeast infection.
Vrlo česte (mogu se javiti u više od 1 na 10 osoba) vaginalna gljivična infekcija.
Very common (may affect more than 1 in 10 people):
Vrlo česte (mogu se javiti kod više od 1 na 10 ljudi):
Very common (may affect more than 1 in 10 people):
Vrlo česte (mogu se javiti kod više od 1 na 10 osoba):
Very common (may affect more than 1 in 10 people):
Vrlo česte (mogu se pojaviti kod više od 1 od 10 osoba):
Very common (may affect more than 1 in 10 people):
Vrlo česte nuspojave (mogu se javiti u više od 1 na 10 osoba):
Very common (may affect more than 1 in 10 people):
Vrlo čestima (mogu se javiti u više od 1 na 10 osoba):
Very common (may affect more than 1 in 10 people):
Vrlo često (mogu se javiti u više od 1 na 10 osoba)
Very common (may affect more than 1 in 10 people):
Vrlo često (mogu se javiti u više od jedne na 10 osoba):
Very Common (may affect more than 1 in 10 people):
Vrlo često (mogu se pojaviti u više od 1 na 10 osoba)
Very common (may affect more than 1 in 10 people):
Vrlo često (pogađa više od 1 od 10 osoba):
Very common (may affect more than 1 in 10 people): abdominal pain.
Vrlo često (mogu se javiti u više od 1 na 10 osoba): bolovi u trbuhu.
Very Common (may affect more than 1 in 10 people): bleeding
Vrlo često (mogu se javiti u više od 1 na 10 osoba): krvarenje
Very common (may affect more than 1 in 10 people): bone, muscle and/or joint pain which is sometimes severe.
Vrlo česte (mogu se javiti u više od 1 na 10 osoba): bolovi u kostima, mišićima i/ili zglobovima, ponekad jaki.
Very common (may affect more than 1 in 10 people): burning sensation and itching
Vrlo često (mogu se pojaviti u više od 1 na 10 korisnika): osjećaj žarenja i svrbež
Very common (may affect more than 1 in 10 people): diarrhoea (generally occurring early on in the treatment, and improving over time), black stools.
Vrlo često (mogu se javiti u više od 1 na 10 osoba): proljev (obično se pojavljivao na početku liječenja i s vremenom je došlo do oporavka), crna solica.
Very common (may affect more than 1 in 10 people): headache
Vrlo često (javljaju se u više od 1 korisnika na 10): glavobolja
Very common (may affect more than 1 in 10 people): if you suffer from high blood pressure and type 2 diabetes with kidney disease, blood tests may show an increased level of potassium.
Vrlo često (mogu se javiti u više od 1 na 10 osoba): ako imate povišen krvni tlak i šećernu bolest tipa 2 te bolest bubrega, krvne pretrage mogu pokazati povišene vrijednosti kalija.
Very common (may affect more than 1 in 10 people): if you suffer from high blood pressure and type 2 diabetes with kidney disease, blood tests may show an increased level of potassium.
Vrlo često (mogu se javiti u više od 1 na 10 osoba): ako imate visoki krvni tlak i šećernu bolest tipa 2 te bolest bubrega, krvne pretrage mogu pokazati povišene vrijednosti kalija.
Very common (may affect more than 1 in 10 people): infections of the upper airway (including infections of the nose and throat).
Vrlo često (mogu se javiti u više od 1 na 10 osoba): infekcije gornjih dišnih putova (uključujući infekcije nosa i grla).
Very common (may affect more than 1 in 10 people): injection site complaints including pain/tenderness/soreness, redness, fever (38.9°C or higher);
Vrlo često (mogu se javiti u više od 1 na 10 osoba): tegobe na mjestu primjene injekcije uključujući bol/osjetljivost ili bol na dodir, crvenilo, vrućica (38,9°C ili viša);
Very common (may affect more than 1 in 10 people): injection site complaints including pain/tenderness/soreness, redness; fever (38.9°C or higher);
Vrlo često (mogu se javiti u više od 1 na 10 osoba): tegobe na mjestu primjene injekcije uključujući bol/osjetljivost ili bol na dodir, crvenilo, vrućica (38,9°C ili viša);
Very common (may affect more than 1 in 10 people): Localised infection
vrlo često (može zahvatiti više od 1 na 10 osoba): lokalizirana infekcija
Very common (may affect more than 1 in 10 people): loss of appetite, headache, constipation (difficulty passing stools), nausea (feeling sick), vomiting, rash, hair loss, tiredness.
Vrlo česte (mogu se javiti u više od 1 na 10 osoba): gubitak teka, glavobolja, zatvor (otežano pražnjenje crijeva), mučnina (osjećaj mučnine), povraćanje, osip, gubitak kose, umor.
Very common (may affect more than 1 in 10 people): nausea
Vrlo često (mogu se javiti u više od 1 na 10 osoba): mučnina
Very common (may affect more than 1 in 10 people): nausea, vomiting, diarrhoea, pain in and around the stomach (abdominal pain), loss of appetite.
vrlo često (mogu se javiti u više od 1 na 10 osoba): mučnina, povraćanje, proljev, bol u i oko želuca (bol u trbuhu), gubitak apetita.
Very common (may affect more than 1 in 10 people): Redness, pain, swelling and itching at the injection site*
Vrlo često (mogu se javiti u više od 1 na 10 osoba): crvenilo, bol, oticanje i svrbež na mjestu injiciranja
Very common (may affect more than 1 in 10 users): formation of neutralising antibodies to factor VIII (inhibitors) in previously untreated patients
Vrlo često (mogu se javiti u više od 1 na 10 korisnika) stvaranje neutralizirajućih protutijela na faktor VIII (inhibitora) u prethodno neliječenih bolesnika
Very common (may affect more than 1 in 10people):
Vrlo često (mogu se javiti u više od 1 na 10 osoba):
Very common (may affect more than 1 in10 people):
Vrlo često (mogu se javiti kod više od 1 na 10 osoba):
Very common (may affect more than 1 patient in 10)
Vrlo česte (mogu se javiti u više od 1 na 10 bolesnika)
Very common (may affect more than 1 user in 10 people)
Vrlo često (mogu se javiti u više od 1 na 10 korisnika)
Very common (may affect more than 1 user in 10)
Vrlo često (mogu se javiti u više od 1 korisnika na 10)
Very common (may affect more than 1 user in 10) are:
Vrlo česte nuspojave (mogu se javiti u više od 1 korisnika na 10):
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana)
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one
Vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana).
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
vrlo česta ( više od 1 do 10 životinja ima nuspojavu tijekom jednog tretmana
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
vrlo česta (više od 1 od ukupno 10 životinja koje pokazuju reakciju tokom jednog tretmana)
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
vrlo česta (više od 1 od ukupno 10 životinja koje pokazuju reakciju tokom jednom tretmana)
Very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
vrlo česte (više od 1 na 10 životinja koje su pokazivale nuspojavu (e) tijekom jednog tretmana
Very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
Vrlo česte (više od 1 na 10 životinja koje su pokazivale nuspojavu (e) tijekom jednog tretmana)
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
vrlo česte (više od 1 na 10 životinja pokazuju nuspojave za vrijeme trajanja tretmana)
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja jednog tretmana)
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana)
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana).
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu/e za vrijeme trajanja jednog tretmana)
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
vrlo česte (više od 1 u 10 životinja pokazuju nuspojave za vrijeme trajanja tretmana)
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
vrlo često (kod više od 1 od 10 životinja kod kojih su se razvile nuspojave tijekom jedne kure liječenja)
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
vrlo često (više od 1 na 10 životinja iskazuje nuspojavu(e) tijekom tretmana)
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
vrlo često (više od 1 na 10 životinja s neželjenom reakcijom tijekom trajanja liječenja)
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
vrlo često (više od 1od 10 životinja pokazuje nuspojavu(e) nakon jednokratne primjene)
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment) common (more than 1 but less than 10 animals in 100 animals)
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana) česte (više od 1 ali manje od 10 životinja na 100 životinja)
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment) common (more than 1 but less than 10 animals in 100 animals)
vrlo česte (više od 1 od 10 životinja pokazuje uočenu(e) nuspojavu(e) za vrijeme jednog liječenja česte (više od 1 ali manje od 10 životinja od 100 životinja)
very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment) common (more than 1 but less than 10 animals in 100 animals).
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana), česte (više od 1 ali manje od 10 životinja na 100 životinja).
Very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment).
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana)
Very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment).
Vrlo česte (više od 1 na 10 životinje koje su pokazivale nuspojavu (e) za vrijeme trajanja jednog tretmana).
very common (more than 1 in 10 animals displaying adverse reactions during the course of one
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja jednog tretmana)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
vrlo česte (tijekom jednog tretiranja nuspojave se manifestiraju kod više od 1 u 10 životinja)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
vrlo česte (u više od 1 na 10 tretiranih životinja uočljive su nuspojave)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
vrlo česte (više od 1 na 10 ţivotinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
vrlo česte (više od 1 na 10 životinja koje su pokazivale nuspojave tijekom jednog tretmana)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
vrlo česte (više od 1 na 10 životinja pokazuju nuspojave za vrijeme trajanja jednog tretmana)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
vrlo česte (više od 1 na 10 životinja pokazuju nuspojave za vrijeme trajanja tretmana)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu za vrijeme trajanja tretmana)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja jednog tretmana)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana),
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
Vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana).
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavue za vrijeme trajanja tretmana)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
vrlo česte (više od 1 u 10 životinja pokazuju nuspojave za vrijeme trajanja jednog tretmana)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
vrlo često (kod više od 1 od 10 životinja kod kojih su se razvile nuspojave tijekom jedne kure liječenja)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
vrlo često (nuspojave se tijekom jednog liječenja javljaju kod više od 1 na 10 životinja)
Very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment),
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana)
very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment).
vrlo česte (više od 1 na 10 životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana)
Very common (more than 1 in 10 animals)
Vrlo česte (više od 1 na 10 životinja pokazuju nuspojave za vrijeme trajanja tretmana)
Very common (side effects which may occur in more than 1 per 10 doses of vaccine):
Vrlo česte (nuspojave koje se mogu javiti kod više od 1 na 10 doza cjepiva):
Very common (these may affect more than 1 in 10 people)
Vrlo često (mogu se javiti u više od 1 na 10 osoba)
Very common (these may affect more than 1 in 10 people) fever (≥38ºC)
Vrlo često (mogu se javiti u više od 1 na 10 osoba)
Very common (These may occur in 1 in 10 doses or more of the vaccine):
Vrlo česte (mogu se pojaviti u 1 na 10 ili više doza cjepiva):
Very common (these may occur with more than 1 in 10 doses of the vaccine)
Vrlo česte (mogu se javiti u više od 1 na 10 doza cjepiva)
Very common (these may occur with more than 1 in 10 doses of the vaccine)
Vrlo često (mogu se javiti kod više od 1 na 10 doza cjepiva)
Very common (≥ 1/10) Common (≥ 1/100 to < 1/10)
vrlo često (≥ 1/10)
Very Common (≥ 1/10) Common (≥ 1/100 to < 1/10)
Vrlo često (≥ 1/10) Često (≥ 1/100 i < 1/10)
Very common (≥ 1/10), common (≥ 1/100 to 1/10), uncommon (≥1/1,000 to 1/100), rare (≥1/10,000 to 1/1,000)
Vrlo često (≥ 1/10), često (≥ 1/100 i 1/10), manje često (≥1/1 000 i 1/100), rijetko (≥1/10 000 i 1/1 000)
Very common (≥ 1/10); Common (≥ 1/100 to < 1/10); Uncommon (≥ 1/1,000 to < 1/100); Rare (≥ 1/10,000 to < 1/1,000); Very rare (< 1/10,000), not known (cannot be estimated from available data).
Vrlo često (≥ 1/10); često (≥ 1/100 do < 1/10); manje često (≥ 1/1000 do < 1/100); rijetko (≥ 1/10 000 do < 1/1000); vrlo rijetko (< 1/10 000), nepoznato (ne mogu se procijeniti iz raspoloživih podataka).
Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data).
Vrlo često (≥ 1/10), često (≥ 1/100 do < 1/10), manje često (≥ 1/1000 do <1/100), rijetko (≥ 1/10 000 do <1/1000), vrlo rijetko (<1/10 000), nepoznato (nije moguće procijeniti iz dostupnih podataka).
Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data).
Vrlo često (≥ 1/10), često (≥ 1/100 do < 1/10), manje često (≥ 1/1000 do <1/100), rijetko (≥ 1/10000 do <1/1000), vrlo rijetko (<1/10000), nepoznato (nije moguće procijeniti iz dostupnih podataka).
Very common (≥ 1/10); Common (≥ 1/100 to < 1/10); Uncommon (≥ 1/1,000 to < 1/100); Rare (≥ 1/10,000 to < 1/1,000); Very rare (< 1/10,000).
Vrlo često (≥ 1/10), često (≥ 1/100 do < 1/10), manje često (≥ 1/1000 do < 1/100), rijetko (≥ 1/10 000 i < 1/1000), vrlo rijetko (<1/10 000).
Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare(< 1/10,000), not known (cannot be estimated from the available data).
Vrlo često (≥ 1/10), često (≥ 1/100 do < 1/10), manje često (≥ 1/1000 do < 1/100), rijetko (≥ 1/10 000 do < 1/1000), vrlo rijetko (< 1/10 000), nepoznato (nije moguće procijeniti iz dostupnih podataka).
Very common (≥ 1/10); Common (≥ 1/100 to < 1/10); Uncommon (≥ 1/1,000 to < 1/100); Rare (≥1/10,000 to <1/1,000); Very rare (<1/10,000).
Vrlo često (≥ 1/10), često (≥ 1/100 do < 1/10), manje često (≥ 1/1000 do < 1/100), rijetko (≥ 1/10 000 i < 1/1000), vrlo rijetko (<1/10 000).
Very common (≥ 1/10); Common (≥ 1/100 to  1/10); Uncommon (≥ 1/1,000 to < 1/100);
Vrlo često (≥ 1/10), često (≥ 1/100 i  1/10), manje često (≥ 1/1000 i < 1/100), rijetko (≥ 1/10 000 i
Very common (≥ 1/10); Common (≥ 1/100, < 1/10); Uncommon (≥ 1/1,000, < 1/100)
MedDRAklasifikaciji organskih sustava i MedDRA izrazu vrlo često (≥ 1/10); često (≥ 1/100 i < 1/10); manje često (≥ 1/1000 i < 1/100)
Very common (≥ 1/10); Common (≥ 1/100, < 1/10); Uncommon (≥ 1/1,000, < 1/100)
Vrlo često (≥ 1/10); Često (≥ 1/100, < 1/10); Manje često (≥ 1/1000, < 1/100)
Very common (≥1/10 patient-years); Common (≥1/100 to <1/10 patient-years);
često (≥1/100 i <1/10 bolesnik-godina);
VERY COMMON (≥1/10)
VRLO ČESTO (≥ 1/10)
Very common (≥1/10)
vrlo često (≥1/10)
Very common (≥1/10)
Često (≥1/100 i <1/10)
Very common (≥1/10) Common (≥1/100 and <1/10)
vrlo često (≥ 1/10) često (≥ 1/100 i < 1/10)
Very common (≥1/10) Common (≥1/100 to < 1/10)
Vrlo često (≥1/10) Često (≥1/100 i < 1/10)
Very common (≥1/10) Common (≥1/100 to <1/10)
Vrlo često (≥1/10) Često (≥1/100 do <1/10)
Very common (≥1/10) Common (≥1/100 to <1/10)
Vrlo često (≥1/10) Često (≥1/100 i <1/10)
Very common (≥1/10), Common (≥1/100 to <1/10), Uncommon (≥1/1,000 to <1/100), Rare (≥1/10,000 to
Vrlo često (≥1/10), često (≥1/100 i <1/10), manje često (≥1/1000 i <1/100), rijetko (≥1/10 000 i
Very common (≥1/10); Common (≥1/100 to <1/10); Uncommon (≥1/1,000 to <1/100);
Vrlo često (≥1/10); često (≥1/100 do <1/10); manje često (≥1/1000 do <1/100); rijetko (≥1/10 000 do
Very common (≥1/10); Common (≥1/100, <1/10); Uncommon (≥1/1,000, <1/100); Rare (≥1/10,000,
Vrlo često (≥1/10); često (≥1/100 i <1/10); manje često (≥1/1000 i <1/100); rijetko (≥1/10 000 i
very common ( 1/10)
vrlo česte ( 1/10)
Very common ( 1/10)
vrlo često (≥ 1/10)
Very common ( 1/10)
Vrlo često ( 1/10)
Very common ( 1/10)
Vrlo često (1/10)
Very common ( 1/10) 1
Vrlo često ( 1/10)1
Very common ( 1/10) Common ( 1/100 to < 1/10)
vrlo često (≥ 1/10) često (≥ 1/100 i < 1/10) manje često (≥ 1/1000 i < 1/100)
Very common (1/10)
vrlo često (≥1/10)
Very common (1/10)
Vrlo često ( 1/10)
Very common (1/10)
Vrlo često (1/10)
Very common (1/10) Common (1/100 to <1/10)
Vrlo često (1/10) Često (1/100 i <1/10)
Very common - Hypoglycaemia
Vrlo često - hipoglikemija
Very common : if you suffer from high blood pressure and type 2 diabetes with kidney disease, blood tests may show an increased level of potassium.
Vrlo često: ako imate povišen krvni tlak i šećernu bolest tipa 2 te bolest bubrega, krvne pretrage mogu pokazati povišene vrijednosti kalija.
Very common : vomiting, nausea, diarrhoea, loss of appetite, fever and sensation of sleep
Vrlo često: povraćanje, mučnina, proljev, gubitak apetita, vrućica i osjećaj pospanosti
Very common > 1/10 Common 1/100 to <1/10
Vrlo često > 1/10
Very common > 1/10 Common 1/100 to <1/10
vrlo često > 1/10 često  1/100 i < 1/10
Very common Abdominal pain, Diarrhoea, Nausea
Vrlo često bol u abdomenu, proljev, mučnina
Very common ADRs from the BR 21 and PA 3 studies are presented in Tables 1 and 3, other ADRs including those from other studies are summarized in Table 4.
Vrlo česte nuspojave iz ispitivanja BR 21 and PA 3 prikazane su u tablicama 1 i 3, a ostale nuspojave uključujući i one iz drugih ispitivanja navedene su u tablici 4.
Very common ADRs in GIOTRIF-treated patients occurring in at least 10% of patients in trial LUX-Lung 3 are summarised by National Cancer Institute-Common Toxicity Criteria (NCI-CTC) Grade in Table 3.
Vrlo česte nuspojave na lijek u bolesnika liječenih GIOTRIFOM koje su se javile kod najmanje 10% bolesnika u ispitivanju LUX-Lung 3 prikazane su u tablici 3 prema stupnjevima Zajedničkih kriterija toksičnosti Nacionalnog instituta za rak (NCI-CTC).
Very common adverse events: decreased appetite (including anorexia); lethargy (including calmness and increased sleeping)
Vrlo uobičajeni neželjeni događaji: smanjeni tek (uključujući anoreksiju); letargija (uključujući mirnoću i pojačano spavanje)